Mouse strains with typical mammalian levels of complement activity - PubMed (original) (raw)
Comparative Study
. 1989 Dec 20;125(1-2):147-58.
doi: 10.1016/0022-1759(89)90088-4.
Affiliations
- PMID: 2607149
- DOI: 10.1016/0022-1759(89)90088-4
Comparative Study
Mouse strains with typical mammalian levels of complement activity
G L Ong et al. J Immunol Methods. 1989.
Abstract
Common laboratory mouse strains have very low complement levels relative to humans, rats, guinea pigs, rabbits and other mammals, which limits the value of the mouse as an experimental model. We therefore tested serum complement levels of 43 mouse strains and 11 rat strains, for the purpose of selecting a convenient laboratory animal having high complement levels. Total complement activity was determined with both erythrocytes and human tumor cells as targets. Eight mouse strains were identified that have complement levels comparable to those of other mammals. These mouse sera lyse tumor cell targets as well as sera from humans, rats or guinea pigs, although they are somewhat less active than rabbit sera. They are relatively inefficient in lysing erythrocyte targets, yet are as active as rabbit serum in this assay. Target cell lysis was demonstrated to be via the classical pathway of complement activation. Of the eight 'high complement' mouse strains, four were recently derived from wild mice, and one, SF/CamEi, was derived from wild mice in 1951. The three other strains, BUB/BnJ, DA/HuSn and RIIIS/J, were developed more than 40 years ago, but apparently were not tested previously for complement activity. Using the BUB mouse as a representative of the 'high complement' mice, we assayed levels of the nine complement components, in an attempt to identify the cause of high complement activity. No difference in levels of C1, C2, C4, C8 or C9 was detected between BUB and BDF1 mice. C2 activity was very low in both strains. C3, C5, C6 and C7 activities were higher in BUB mice than in BDF1 mice, indicating that variation in these complement components is responsible for the difference in total complement activity. The genes determining the 'high complement' phenotype appeared to be semi-dominant in F1 hybrids. The 'high-complement' mouse strains, and recombinant strains derived from them, will be useful in a wide range of biomedical research.
Similar articles
- Analysis of high complement levels in Mus hortulanus and BUB mice.
Ong GL, Baker AE, Mattes MJ. Ong GL, et al. J Immunol Methods. 1992 Sep 18;154(1):37-45. doi: 10.1016/0022-1759(92)90210-k. J Immunol Methods. 1992. PMID: 1401942 - Complement in BuB/BnJ mice revisited: serum C3 levels and complement opsonic activity are not elevated.
Osmers I, Szalai AJ, Tenner AJ, Barnum SR. Osmers I, et al. Mol Immunol. 2006 Apr;43(10):1722-5. doi: 10.1016/j.molimm.2005.10.004. Epub 2005 Nov 28. Mol Immunol. 2006. PMID: 16310250 - Homologous species restriction in lysis of erythrocytes by terminal complement proteins.
Hänsch GM, Hammer CH, Vanguri P, Shin ML. Hänsch GM, et al. Proc Natl Acad Sci U S A. 1981 Aug;78(8):5118-21. doi: 10.1073/pnas.78.8.5118. Proc Natl Acad Sci U S A. 1981. PMID: 6946459 Free PMC article. - The functional significance of complement.
Fearon DT, Ruddy S, Knostman JD, Carpenter CB, Austen KF. Fearon DT, et al. Adv Nephrol Necker Hosp. 1974;4:15-35. Adv Nephrol Necker Hosp. 1974. PMID: 4219991 Review. No abstract available. - [Complement system].
Korol' SA. Korol' SA. Fiziol Zh. 1977 May-Jun;23(3):408-16. Fiziol Zh. 1977. PMID: 326583 Review. Ukrainian. No abstract available.
Cited by
- Efficient generation of human immune system rats using human CD34+ cells.
Ménoret S, Renart-Depontieu F, Martin G, Thiam K, Anegon I. Ménoret S, et al. Stem Cell Reports. 2024 Sep 10;19(9):1255-1263. doi: 10.1016/j.stemcr.2024.07.005. Epub 2024 Aug 15. Stem Cell Reports. 2024. PMID: 39151431 Free PMC article. - A predominately pulmonary activation of complement in a mouse model of severe COVID-19.
Szachowicz PJ, Wohlford-Lenane C, Heinen CJ, Ghimire S, Xue B, Boly TJ, Verma A, MašinoviĆ L, Bermick JR, Perlman S, Meyerholz DK, Pezzulo AA, Zhang Y, Smith RJH, McCray PB Jr. Szachowicz PJ, et al. bioRxiv [Preprint]. 2024 Jun 3:2024.05.31.596892. doi: 10.1101/2024.05.31.596892. bioRxiv. 2024. PMID: 38895461 Free PMC article. Preprint. - Therapeutic Intervention of Neuroinflammatory Alzheimer Disease Model by Inhibition of Classical Complement Pathway with the Use of Anti-C1r Loaded Exosomes.
Richards T, Perron JC, Patel K, Wurpel J, Reznik SE, Schanne F. Richards T, et al. Res Sq [Preprint]. 2023 Oct 18:rs.3.rs-3399248. doi: 10.21203/rs.3.rs-3399248/v1. Res Sq. 2023. PMID: 37886595 Free PMC article. Preprint. - Macrophage-mediated trogocytosis contributes to destroying human schistosomes in a non-susceptible rodent host, Microtus fortis.
Shen J, Zhao S, Peng M, Li Y, Zhang L, Li X, Hu Y, Wu M, Xiang S, Wu X, Liu J, Zhang B, Chen Z, Lin D, Liu H, Tang W, Chen J, Sun X, Liao Q, Hide G, Zhou Z, Lun ZR, Wu Z. Shen J, et al. Cell Discov. 2023 Oct 5;9(1):101. doi: 10.1038/s41421-023-00603-6. Cell Discov. 2023. PMID: 37794085 Free PMC article. - Antibodies against Poly(ethylene glycol) Activate Innate Immune Cells and Induce Hypersensitivity Reactions to PEGylated Nanomedicines.
Chen WA, Chang DY, Chen BM, Lin YC, Barenholz Y, Roffler SR. Chen WA, et al. ACS Nano. 2023 Mar 28;17(6):5757-5772. doi: 10.1021/acsnano.2c12193. Epub 2023 Mar 16. ACS Nano. 2023. PMID: 36926834 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous